BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19608998)

  • 1. Thalidomide in small cell lung cancer: wrong drug or wrong disease?
    Rüegg C; Peters S
    J Natl Cancer Inst; 2009 Aug; 101(15):1034-5. PubMed ID: 19608998
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
    Musallam KM; Taher AT
    J Natl Cancer Inst; 2009 Dec; 101(23):1657; author reply 1657-8. PubMed ID: 19858426
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging drugs for small-cell lung cancer.
    Metro G; Cappuzzo F
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):591-606. PubMed ID: 19694501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
    Bregni M; Pedrazzoli P
    J Natl Cancer Inst; 2009 Jan; 101(1):67; author reply 67-8. PubMed ID: 19116385
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in management of small-cell lung cancer.
    Chua YJ; Steer C; Yip D
    Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy in small-cell lung cancer: lessons learned and future directions.
    Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):998-1003. PubMed ID: 21353159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
    Lee SM; Woll PJ; Rudd R; Ferry D; O'Brien M; Middleton G; Spiro S; James L; Ali K; Jitlal M; Hackshaw A
    J Natl Cancer Inst; 2009 Aug; 101(15):1049-57. PubMed ID: 19608997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of limited disease small cell lung cancer.
    De Ruysscher D
    Eur J Cancer; 2009 Sep; 45 Suppl 1():425-6. PubMed ID: 19775657
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic cranial irradiation in small-cell lung cancer.
    Fujiwara Y; Hotta K; Kiura K
    N Engl J Med; 2007 Nov; 357(19):1977-8; author reply 1978. PubMed ID: 17992731
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic Cranial Irradiation in Resected Early-Stage Small Cell Lung Cancer.
    Eze C; Roengvoraphoj O; Manapov F
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):612-614. PubMed ID: 28581402
    [No Abstract]   [Full Text] [Related]  

  • 11. [Small-cell lung cancer].
    Pérez-Gracia JL; López-Picazo JM; Martín-Algarra S; Viteri S; García-Foncillas J; Gúrpide A
    Rev Med Univ Navarra; 2007; 51(2):7-13. PubMed ID: 17886708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New advances in the second-line treatment of small cell lung cancer.
    Hurwitz JL; McCoy F; Scullin P; Fennell DA
    Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controversial treatment of brain metastases of small-cell lung cancer. Randomized comparison of chemotherapy alone and radiochemotherapy].
    Fietkau R
    Strahlenther Onkol; 2001 Jun; 177(6):314-6. PubMed ID: 11446322
    [No Abstract]   [Full Text] [Related]  

  • 14. Extensive-stage small-cell lung cancer--moving beyond response rate?
    Ferraldeschi R; Lorigan P
    Ann Oncol; 2009 May; 20(5):801-2. PubMed ID: 19403933
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of extensive disease small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    Grigoriu B; Meert AP;
    Rev Med Brux; 2014; 35(3):164-8. PubMed ID: 25102583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of rational development of complex natural products as cancer therapeutics.
    White J
    J Natl Cancer Inst; 2010 Jun; 102(12):834-5. PubMed ID: 20505150
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress and pitfalls in small-cell lung cancer.
    Kalemkerian GP
    Oncology (Williston Park); 2008 Nov; 22(13):1498-500, 1506. PubMed ID: 19227572
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.
    Young RJ; Tin AW; Brown NJ; Jitlal M; Lee SM; Woll PJ
    Br J Cancer; 2012 Mar; 106(6):1153-9. PubMed ID: 22353811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in small-cell lung cancer: is it a tombstone?
    Rossi A; Gridelli C; Bria E
    J Clin Oncol; 2008 Jan; 26(1):160; author reply 160. PubMed ID: 18165652
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic issues in small cell lung cancer.
    Lopez-Chavez A; Sandler A
    Curr Probl Cancer; 2012; 36(3):131-55. PubMed ID: 22633107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.